Cytomegalovirus Reactivation in a Patient With Extensively Pretreated Multiple Myeloma During Daratumumab Treatment

Kristine A Frerichs¹, Patricia W C Bosman¹, Inger S Nijhof¹, Sonja Zweegman¹, Niels W C J van de Donk²

Affiliations

¹ Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
² Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands. Electronic address: n.vandedonk@vumc.nl.

PMID: 30392824
PMCID: PMC7104728
DOI: 10.1016/j.clml.2018.10.002

Case Reports

Cytomegalovirus Reactivation in a Patient With Extensively Pretreated Multiple Myeloma During Daratumumab Treatment

Kristine A Frerichs et al. Clin Lymphoma Myeloma Leuk. 2019 Jan.

. 2019 Jan;19(1):e9-e11.

doi: 10.1016/j.clml.2018.10.002. Epub 2018 Oct 13.

Authors

Kristine A Frerichs¹, Patricia W C Bosman¹, Inger S Nijhof¹, Sonja Zweegman¹, Niels W C J van de Donk²

Affiliations

¹ Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
² Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands. Electronic address: n.vandedonk@vumc.nl.

PMID: 30392824
PMCID: PMC7104728
DOI: 10.1016/j.clml.2018.10.002

No abstract available

Keywords: CD38 antibodies; CMV; Infectious complication; Plasma cell dyscrasia; Viral infection.

PubMed Disclaimer

Cited by

Hepatitis B virus reactivation in a myeloma patient with resolved infection who received daratumumab-containing salvage chemotherapy.
Kikuchi T, Kusumoto S, Tanaka Y, Oshima Y, Fujinami H, Suzuki T, Totani H, Kinoshita S, Asao Y, Narita T, Ito A, Ri M, Komatsu H, Iida S. Kikuchi T, et al. J Clin Exp Hematop. 2020 Jun 20;60(2):51-54. doi: 10.3960/jslrt.19034. Epub 2020 May 13. J Clin Exp Hematop. 2020. PMID: 32404569 Free PMC article.
Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network.
Ludwig H, Boccadoro M, Moreau P, San-Miguel J, Cavo M, Pawlyn C, Zweegman S, Facon T, Driessen C, Hajek R, Dimopoulos MA, Gay F, Avet-Loiseau H, Terpos E, Zojer N, Mohty M, Mateos MV, Einsele H, Delforge M, Caers J, Weisel K, Jackson G, Garderet L, Engelhardt M, van de Donk N, Leleu X, Goldschmidt H, Beksac M, Nijhof I, Abildgaard N, Bringhen S, Sonneveld P. Ludwig H, et al. Leukemia. 2021 Jan;35(1):31-44. doi: 10.1038/s41375-020-01016-0. Epub 2020 Aug 19. Leukemia. 2021. PMID: 32814840 Free PMC article. Review.
Do cytomegalovirus infections affect the daratumumab treatment course in multiple myeloma patients? - Literature review.
Ferreira LM, Cerezer JL, Gehrcke M. Ferreira LM, et al. Hematol Transfus Cell Ther. 2021 Apr-Jun;43(2):185-190. doi: 10.1016/j.htct.2020.05.009. Epub 2020 Jul 22. Hematol Transfus Cell Ther. 2021. PMID: 32737019 Free PMC article. Review.
Daratumumab is a safe and effective rescue therapy for multiple myeloma patients who relapse after allo-HSCT.
Gonzalez-Rodriguez AP, Lopez-Corral L, Fajardo DFM, Gonzalez-Huerta AJ, Palomo P, Bermudez A, Ripa TZ, Santos-Diaz P, Gonzalez-Muñiz S, Zanabilli J, Jimenez Ubieto A, de Arriba F, Arnao-Herraiz M, Sordo-Bahamonde C, López-Soto A, Gonzalez S, Rosiñol L, Mateos MV. Gonzalez-Rodriguez AP, et al. Bone Marrow Transplant. 2020 Feb;55(2):461-463. doi: 10.1038/s41409-019-0525-1. Epub 2019 Apr 15. Bone Marrow Transplant. 2020. PMID: 30988379 No abstract available.
Cytomegalovirus infection during daratumumab therapy in patients with newly diagnosed multiple myeloma.
Kikuchi T, Tsukada N, Kunisada K, Nomura-Yogo M, Oda Y, Sato K, Takei T, Ogura M, Abe Y, Suzuki K, Ishida T. Kikuchi T, et al. Int J Hematol. 2024 Jul;120(1):91-95. doi: 10.1007/s12185-024-03770-8. Epub 2024 Apr 19. Int J Hematol. 2024. PMID: 38639848

See all "Cited by" articles

References

1. Ljungman P., Boeckh M., Hirsch H.H. Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials. Clin Infect Dis. 2017;64:87–91. - PubMed
1. Styczynski J. Who is the patient at risk of CMV recurrence: a review of the current scientific evidence with a focus on hematopoietic cell transplantation. Infect Dis Ther. 2018;7:1–16. - PMC - PubMed
1. Marchesi F., Pimpinelli F., Ensoli F., Mengarelli A. Cytomegalovirus infection in hematologic malignancy settings other than the allogeneic transplant. Hematol Oncol. 2018;36:381–391. - PubMed
1. Drylewicz J., Schellens I.M., Gaiser R. Rapid reconstitution of CD4 T cells and NK cells protects against CMV-reactivation after allogeneic stem cell transplantation. J Transl Med. 2016;14:230. - PMC - PubMed
1. Schutt P., Brandhorst D., Stellberg W. Immune parameters in multiple myeloma patients: influence of treatment and correlation with opportunistic infections. Leuk Lymphoma. 2006;47:1570–1582. - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Cytomegalovirus Reactivation in a Patient With Extensively Pretreated Multiple Myeloma During Daratumumab Treatment

Affiliations

Cytomegalovirus Reactivation in a Patient With Extensively Pretreated Multiple Myeloma During Daratumumab Treatment

Authors

Affiliations

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Research Materials